Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Human Cathelicidin CAP18/LL-37 Changes Mast Cell Function toward Innate Immunity
Mino Yoshioka, Nobuyuki Fukuishi, Yuichi Kubo, Hiroyuki Yamanobe, Kanae Ohsaki, Yoshiko Kawasoe, Mana Murata, Aya Ishizumi, Yumiko Nishii, Nobuaki Matsui, Masaaki Akagi
著者情報
ジャーナル フリー

2008 年 31 巻 2 号 p. 212-216

詳細
抄録
The antimicrobial peptide LL-37 is generated from skin keratinocytes during infection of Gram-negative bacteria and exerts a microbicidal effect. LL-37 also causes functional changes in mast cells. Mast cells in the skin are involved in the innate immune system response against microbial infections via Toll-like receptors (TLRs), such as TLR4, which that is known to recognize lipopolysaccharide (LPS), a bacterial component. Thus, in the present study, we examined the effects of LL-37 on the expression of TLRs and the generation of cytokines on mast cells, and considered functional changes in the host defense system against bacteria. We observed that LL-37 increased the level of TLR4 mRNA and TLR4 protein, and that LL-37 induced the release of IL-4, IL-5 and IL-1β from mast cells. Cross-interaction between LL-37-triggered TLR4 augmentation and LL-37-inducible cytokine generation was also examined. Although the up-regulation of LL-37-inducible Th2 cytokines was cancelled by LPS, the augmentation of pro-inflammatory cytokine production was still observed. These findings indicate that LL-37 co-existing with the bacterial component switches mast cell function and directs human mast cells toward innate immunity. In conclusion, LL-37 may be a candidate modifier of the host defense against bacterial entry by serving as an alarm for sentinels such as mast cells.
著者関連情報
© 2008 The Pharmaceutical Society of Japan
前の記事 次の記事
feedback
Top